Literature DB >> 33235140

Pediatric Gliosarcoma With and Without Neurofibromatosis Type 1: A Whole-exome Comparison of 2 Patients.

Richard T Graham1, Erica H Bell2, Amy Webb3, Yue Zhao3, Cynthia Timmers4, Jessica L Fleming2, Blake E Sells2, Nathan J Robison5, Joshua D Palmer2, Jonathan L Finlay6, Arnab Chakravarti2.   

Abstract

Gliosarcoma is rare among pediatric patients and among individuals with Neurofibromatosis Type 1 (NF1). Here we compare 2 pediatric gliosarcoma patients, one of whom has NF1. We performed whole-exome sequencing, methylation, and copy number analysis on tumor and blood for both patients. Whole-exome sequencing showed higher mutational burden in the tumor of the patient without NF1. Copy number analysis showed differences in chromosomal losses/gains between the tumors. Neither tumor showed O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation. The NF1 patient survived without progression while the other expired. This is the first reported case of gliosarcoma in a child with NF1.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33235140     DOI: 10.1097/MPH.0000000000002020

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  1 in total

1.  Gliosarcoma in patients under 20 years of age. A clinicopathologic study of 11 cases and detailed review of the literature.

Authors:  Nasir Ud Din; Hira Ishtiaq; Shabina Rahim; Jamshid Abdul-Ghafar; Zubair Ahmad
Journal:  BMC Pediatr       Date:  2021-02-26       Impact factor: 2.125

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.